IL6 and depressive symptom measurement: Notably, breast cancer survivors are more likely than the general population to develop depression [8]; several studies that have evaluated the role of proinflammatory cytokines (such as IL-6 and IFNγ) in the development of depression in patients with breast cancer have found positive relationships between proinflammatory cytokines and depression [9–17].